Evaluating the efficacy of using large language models in preoperative prediction of microvascular invasion in HCC: a multicenter study

评估大型语言模型在肝细胞癌术前预测微血管侵犯中的有效性:一项多中心研究

阅读:1

Abstract

Primary liver cancer is the sixth most commonly diagnosed cancer globally and the third leading cause of cancer-related deaths. Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer, and microvascular invasion (MVI) is a significant risk factor affecting postoperative prognosis in HCC. However, accurately predicting MVI preoperatively remains a challenge. This study aims to evaluate the application of large language models (LLMs), specifically ChatGPT 4o, in predicting MVI in HCC and to compare its performance with traditional clinical models. In this retrospective study, 300 HCC patients who underwent curative liver resection between June 2018 and December 2018 were selected at two centers. The collected clinical data included age, gender, HBV infection, liver cirrhosis, AFP levels, and more. ChatGPT 4o were used to process the clinical data of the patients and predict MVI. Subsequently, the predictive results of the ChatGPT 4o were compared with machine learning models, the ROC curves were plotted, and AUC was calculated. The results showed that the AUC of the ChatGPT 4o was 0.755. Machine learning algorithms use Random Forest, Support Vector Machine, Logistic Regression, XGBoost and Decision Tree, the AUC of 5 machine learning algorithms was range from 0.534 to 0.624. ChatGPT 4o achieved the highest AUC and showed statistically significant differences compared to Support Vector Machine, Logistic Regression and Decision Tree. Additionally, the predictive results of the ChatGPT 4o effectively stratified the postoperative overall survival (OS) and recurrence-free survival (RFS) of HCC patients. LLMs have demonstrated significant predictive capabilities for MVI in HCC and for risk stratification regarding postoperative OS and RFS. These advancements possess substantial potential to enhance preoperative management and make surgical planning.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。